L’Oréal reported a 13 percent rise in first-quarter sales, beating expectations thanks to strong business in the US and Europe as shoppers shrugged off rising prices, but said it had not benefited yet from the end of Covid-19 curbs in China.

Sales of the French cosmetics group, which sells brands ranging from Maybelline to Lancôme, came to €10.38 billion ($11.37 billion) over the first three months to the end of March.

The 13 percent increase on an organic basis beat analyst expectations for 8.1 percent growth, according to a consensus estimate cited by Barclays.

Sales in Europe and North America grew by 16 percent and 16.6 percent, respectively, with the company flagging a strong performance from its consumer products, which has been moving upmarket, as well as its dermatological beauty division, which sells CeraVe skincare.

In mainland China, where the company said luxury sales were flat due to low inventories, consumer demand and store traffic resumed from February.

Earlier this month, L'Oréal agreed to buy Australian luxury brand Aesop for an enterprise value of $2.53 billion, its largest brand acquisition to date, with an eye to international expansion, including in China.

By Mimosa Spencer, Editor Silvia Aloisi

Opens in new window

Learn more:

Why L’Oréal Paid $2.5 Billion for Aesop

The internet’s most memed skincare line, beloved by both insiders and strivers, gives the conglomerate a chance to reconstruct its luxury portfolio.